Skip to main content
. 2021 Apr;10(4):765–772. doi: 10.21037/tp-20-358

Table 2. Baseline demographics and success of sedation.

Variables Total (n=105) Successful sedation (n=60) Failed sedation (n=45) P value
Age (month) 20.0 (9.0–37.0) 24.5 (11.0–43.0) 13.0 (8.0–28.0) 0.024*
Weight (kg) 11.0 (8.4–13.7) 11.6 (8.7–15.3) 9.9 (7.8–11.7) 0.014*
Male, n (%) 62 (59.0) 35 (58.3) 27 (60.0) 1.000
Ethnicity, n (%) 0.476
   Chinese 47 (46.1) 23 (38.3) 24 (53.3)
   Malay 22 (21.6) 15 (25.0) 7 (15.6)
   Indian 8 (7.8) 5 (8.3) 3 (6.6)
   Others 25 (24.5) 11 (18.3) 7 (15.6)
Indications, n (%) <0.001*
   AABR 12 (11.4) 10 (16.7) 2 (4.4)
   CT 30 (28.6) 25 (41.7) 5 (11.1)
   DMSA 4 (3.8) 3 (5.0) 1 (2.2)
   MAG3 3 (2.9) 3 (5.0) 0 (0.0)
   MRI 56 (53.3) 19 (31.7) 37 (82.2)
Length of procedure 0.001*
   Long procedure 75 (71.4) 35 (58.3) 40 (88.9)
   Short procedure 30 (28.6) 25 (41.7) 5 (11.1)
Sedation details
   Onset of action (min) 15.4±7.0 14.9±7.7 16.2±5.7 0.366
   Duration of sedation (min) 88.6±60.7 107.2±64.6 60.3±40.8 <0.001*
   Dose (μg/kg) 3.1±0.5 3.1±0.4 3.1±0.5 0.372

*, P value <0.05; , median (interquartile range). AABR, automated auditory brainstem response; CT, computerized tomography; DMSA, dimercaptosuccinic acid renal scan; MAG3, mercaptoacetyltriglycine 3 renogram; MRI, magnetic resonance imaging.